Pulmonary Function Testing (PFT) is a vital tool in diagnosing and managing respiratory diseases. However, interpreting the results can be complex for healthcare professionals. This guide aims to simplify the process.
Spirometry, the most common PFT, measures the amount (volume) and speed (flow) of air that can be inhaled and exhaled. Key values include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Abnormalities in these values can indicate obstructive or restrictive lung diseases.
Obstructive disorders, such as COPD and asthma, are characterized by reduced airflow. This is reflected in a decreased FEV1/FVC ratio. On the other hand, restrictive disorders like pulmonary fibrosis present with reduced lung volumes (FVC), but normal or increased FEV1/FVC ratio.
Gas exchange tests, such as the diffusion capacity for carbon monoxide (DLCO), provide insight into the lung’s ability to transfer gases between the alveoli and the bloodstream. Reduced DLCO can indicate diseases like emphysema or pulmonary hypertension.
Interpretation of PFT results should always be integrated with the patient's symptoms, physical examination, and other diagnostic tests. For instance, a reduced FEV1/FVC ratio accompanied by wheezing and episodic breathlessness may suggest asthma.
Interpreting PFT results is a nuanced process that requires a comprehensive understanding of respiratory physiology and clinical context. By understanding spirometry and gas exchange testing, and recognizing obstructive and restrictive patterns, healthcare professionals can more accurately diagnose and manage respiratory diseases.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation